Delivery Order SPE2DB20D1050-SPE2DB24FH74D

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,445.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MUCINEX DM ER 600-30 MG TABLET 20S. The contract is a firm fixed price delivery order, with an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential value of $999,999,999.00 and a performance...
This federal contract award, valued at $1,161.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mucinex DM ER 600-30 MG Tablet, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mucinex DM ER 600-30 MG Tablets. The contract has a ceiling value of $1,188.48 and a completion date of July 26, 2024. It is a delivery order contract with a firm fixed price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, through its Corporate Office division, has been a...
This federal contract award, valued at $1,814.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mucinex DM ER 600-30 mg tablets, a 20-count product, with a completion date of July 29, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. This award is not set aside for any specific business categories. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,817.41 Firm Fixed Price Delivery Order contract is for the supply of MUCINEX DM ER 600-30 MG TABLET 20S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00, which provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,947.00, is for the delivery of Mucinex DM ER 600-30 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of July 1, 2024. This contract award is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mucinex DM ER 600-30 mg tablets, with a ceiling value of $2,850 and a completion date of January 22, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,279.56, is for the delivery of 4,565,309,927 MUCINEX ER 600 MG TABLET 20S. This is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a wide range of medical...
This federal contract award, valued at $19,809.03, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of pharmaceutical products, specifically Mucinex DM 600-30mg tablets, to support government medical supply requirements. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,656.48 Firm Fixed Price delivery order is for the supply of MUCINEX DM ER 600-30 MG TABLET 40S, a pharmaceutical product. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D1050
    Indefinite Delivery Contract
  • SPE2DB20D1050-SPE2DB24FH74D
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MUCINEX DM ER 600-30 MG TABLET 20S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,082.48, is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 9/19/24, 9:29 AM